Robert Kernstock, PhD

(Astellas Pharma US) – Dr. Kernstock is a member of Astellas’ Science WoRx steering committee that focuses on fostering science education at the elementary and high school grade levels. As part of the program, he has helped many high school students on projects in the STEM lab, including one to identify potential biomarkers for Alzheimer’s

Chris Reddick, PhD

(Takeda Pharmaceuticals USA) – Dr. Reddick is works to improve access to healthcare and medicines for patients living in extreme poverty in underdeveloped communities worldwide. In 2012, he started Healthcare Partners for Children, an organization that provides opportunities for healthcare professionals to directly impact the lives of patients and people in need beyond their daily

Norris Turner Jr., PharmD, PhD

(Janssen Pharmaceutical Companies of Johnson & Johnson) Norris helps develop and drive programs aimed at elevating the standard of care for those with serious mental illness. Through legislative advocacy and community outreach, he champions policy solutions and population health management strategies that support earlier treatment interventions and enhanced collaboration between the mental health and criminal

Keya Pitts

Over the past several years, Keya has been a passionate volunteer in iBio Institute’s Stellar Girls program. As part of these efforts, she has mentored and coached girls (grades 3-8) in the fields of science, technology, engineering and mathematics, helping to diversify the STEM talent pipeline. Keya also has inspired young women and minorities to

Adam Price

Adam works with BI’s state lobbyists to educate state legislators on employment and data privacy issues, such as paid family and medical leave and harassment, as well as BI’s current policies and procedures. Through his work, legislators have the knowledge to make informed decisions about employment-related legislation. In addition, Adam provided BI’s unique perspective on

Don Raineri, Pharm.D.

In the past year, Don has helped lead the company’s efforts to enhance diversity in clinical trials participation, including shepherding development of an implementation plan specific to PhRMA’s revised clinical trials principles. Don has also represented Astellas in discussions on the reauthorization of the Prescription Drug User Fee Act (PDUFA), working to encourage an efficient

Deborah Reardon

Deb consistently goes beyond her traditional day-to-day responsibilities to advance policy priorities at both the state and federal level. Her ability to simply translate complicated schematics has been invaluable in educating and engaging diverse stakeholders on some of the industry’s most pressing policy fronts — including co-pay accumulator bans, rebate pass-through and improved transparency around

Paul Richardson

Paul is a special type of researcher who can translate scientific concepts into themes and messages that resonate with non-scientists. He communicates the value of the critical work of pharmaceutical research in understandable, impactful ways to key elected officials, advocates and the public visiting Pfizer’s La Jolla, California site for many years now. Additionally, he

David Riggs

David and his colleague, Caroline Rosewell, were the team leaders in the company’s efforts to set up monoclonal antibody infusion clinics across the state of Indiana. These clinics not only helped get the treatment out to at-risk patients across the state, but they also served as an important tutorial and “how to” for hospitals and

Michele Schmidt, RN

(Celgene Corporation) As a “Celgene Ambassador,” Michele has been a tremendous partner to the Government Relations teams in helping them understand and communicate Celgene’s clinical trials footprint to legislators across the United States. She helped create the first Celgene State Fact Sheets to demonstrate Celgene’s presence in states across the country – an important tool